Iris K. Sokka

Synthesis and In Vitro Evaluation of a Set of 6-Deoxy-6-thio-carboranyl d-Glucoconjugates Shed Light on the Substrate Specificity of the GLUT1 Transporter

M. Sarparanta, E. Hey‐Hawkins, J. Rautio, 2022, ACS omega.

Exploring the Biochemical Foundations of a Successful GLUT1-Targeting Strategy to BNCT: Chemical Synthesis and In Vitro Evaluation of the Entire Positional Isomer Library of ortho-Carboranylmethyl-Bearing Glucoconjugates.

Mikael P. Johansson, M. Sarparanta, A. Airaksinen, 2020, Molecular pharmaceutics.

Improving the Potency of Auristatin Cancer Drugs by Virtual Structure Modifications

Iris K. Sokka, 2019 .

Addressing the Biochemical Foundations of a Glucose-Based “Trojan Horse”-Strategy to Boron Neutron Capture Therapy: From Chemical Synthesis to In Vitro Assessment

Mikael P. Johansson, M. Sarparanta, A. Airaksinen, 2020, Molecular pharmaceutics.

Increasing the Potential of the Auristatin Cancer-Drug Family by Shifting the Conformational Equilibrium

Mikael P. Johansson, Iris K Sokka, F. Ekholm, 2019, Molecular pharmaceutics.

Halogenation at the Phenylalanine Residue of Monomethyl Auristatin F Leads to a Favorable cis/trans Equilibrium and Retained Cytotoxicity

Mikael P. Johansson, M. Sarparanta, H. Maaheimo, 2021, Molecular pharmaceutics.

Sweet Battle of the Epimers—Continued Exploration of Monosaccharide-Derived Delivery Agents for Boron Neutron Capture Therapy

M. Sarparanta, E. Hey‐Hawkins, J. Rautio, 2023, Molecular pharmaceutics.